Actelion Ltd - Strategy, SWOT and Corporate Finance Report
SummaryActelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Actelion Ltd. (Actelion or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company classifies its business into single segment, which primarily focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, central nervous system disorders, infectious diseases, cancer, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.
Scope
- Detailed information on Actelion Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
- Intelligence on Actelion Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Actelion Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Actelion Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Actelion Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Actelion Ltd's business structure, strategy and prospects.
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. The company's primary areas of focus include viral diseases, inflammatory and fibrotic diseases and oncology. The company's products include: Biktarvy for the treatment of HIV-1 infection in certain patients; Vosevi?, a single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment of chronic hepatitis C virus infection in adults; Vemlidy? for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; and Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
GlaxoSmithKline is a global healthcare company. Co.'s segments include: Pharmaceuticals; Vaccines; and Consumer Healthcare. The Pharmaceuticals segment is focused on developing new medicines in respiratory, HIV, oncology and immuno-inflammation, with discovery research exploring these and other areas. The Vaccines segment has a portfolio and pipeline of vaccines to help protect people throughout life. Co. delivers vaccines to people living in over 160 countries. The Consumer Healthcare segment develops and markets consumer-preferred brands in oral health, pain relief, respiratory, nutrition/gastro-intestinal and skin health.
Kuros Biosciences is engaged in the discovery, development, and commercialization of biopharmaceutical products for use in the treatment and prevention of chronic diseases in Switzerland, and the United States. Co. develops Immunodrugs, a class of biopharmaceutical products that are intended for use in the prevention and treatment of chronic diseases, as well as to activate the patient's immune system to induce specific antibody and targeted T cell responses to modulate chronic disease processes. Co.'s product candidate, NIC002, is in Phase II clinical trials and is intended for the treatment of nicotine addiction.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.